ANTENGENE-B News

ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

May 3 16:51

ANTENGENE-B: FORM OF PROXY FOR THE ANNUAL GENERAL MEETING

Apr 29 17:09

ANTENGENE-B: Notification Letter to Registered Shareholders and Reply Form

Apr 29 17:06

ANTENGENE-B: Notification Letter to Non-registered Holders and Reply Form

Apr 29 17:05

ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 3 16:53

ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

Mar 4 16:08

ANTENGENE-B: Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

Feb 26 16:35

ANTENGENE-B: Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

Feb 26 16:30

ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

Feb 1 16:25

ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

Jan 4 16:25

ANTENGENE-B: VOLUNTARY ANNOUNCEMENT SELINEXOR (XPOVIO), ANTENGENE''S FIRST-IN-CLASS NEW DRUG, SUCCESSFULLY INCLUDED IN 2023 NATIONAL REIMBURSEMENT DRUG LIST

Dec 14, 2023 06:50

ANTENGENE-B: VOLUNTARY ANNOUNCEMENT APPROVAL OF NDA BY THE PHARMACEUTICAL ADMINISTRATION BUREAU OF MACAU FOR ATG-010 (SELINEXOR) FOR THE TREATMENT OF RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA

Dec 6, 2023 16:30

ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023

Dec 5, 2023 16:25

ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023

Nov 3, 2023 16:25

ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023

Oct 5, 2023 16:25

ANTENGENE-B: NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS

Sep 27, 2023 16:54

ANTENGENE-B: VOLUNTARY ANNOUNCEMENT UNUSUAL PRICE AND TRADING VOLUME MOVEMENT

Sep 18, 2023 08:08

ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023

Sep 5, 2023 17:51

ANTENGENE-B: INSIDE INFORMATION COLLABORATION AGREEMENT BETWEEN ANTENGENE AND HANSOH PHARMA FOR THE COMMERCIALIZATION OF XPOVIO (SELINEXOR) IN THE MAINLAND OF CHINA

Aug 11, 2023 08:00

ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023

Aug 3, 2023 16:25